Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. NC3880874

BIOFARGO INC NK Cell Activator (OK432) 100µG

Catalog No. NC3880874
Encompass_Preferred

OK-432 is an immunomodulatory reagent prepared from the lyophilized, penicillin-inactivated Su strain of Group A Streptococcus pyogenes. In peripheral blood mononuclear cell (PBMC) cultures, OK-432 activates myeloid cells (monocytes/macrophages and dendritic cells), which subsequently release IL-12 and other cytokines that drive natural killer (NK) cell activation. Activated cells exhibit increased IFN-γ production, degranulation, and cytotoxic activity. OK-432 can also enhance neutrophil-mediated tumoricidal effects (e.g., via CD11b/CD18–ICAM-1 interactions) and induce LAK-like activity in lymphocytes. Owing to these immunostimulatory properties, OK-432 is widely used in vitro as a research-use-only NK-cell activator for NK/LAK activation workflows, ADCC assay development, dendritic-cell maturation, and tumor-immunology studies.

Catalog No. NC3880874 Supplier BIOFARGO INC Supplier No. GMPTL1070100
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

OK-432 is an immunomodulatory reagent prepared from the lyophilized, penicillin-inactivated Su strain of Group A Streptococcus pyogenes. In peripheral blood mononuclear cell (PBMC) cultures, OK-432 activates myeloid cells (monocytes/macrophages and dendritic cells), which subsequently release IL-12 and other cytokines that drive natural killer (NK) cell activation. Activated cells exhibit increased IFN-γ production, degranulation, and cytotoxic activity. OK-432 can also enhance neutrophil-mediated tumoricidal effects (e.g., via CD11b/CD18–ICAM-1 interactions) and induce LAK-like activity in lymphocytes. Owing to these immunostimulatory properties, OK-432 is widely used in vitro as a research-use-only NK-cell activator for NK/LAK activation workflows, ADCC assay development, dendritic-cell maturation, and tumor-immunology studies.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.